Andreas Eisenreich

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. ncbi Overexpression of alternatively spliced tissue factor induces the pro-angiogenic properties of murine cardiomyocytic HL-1 cells
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, Berlin, Germany
    Circ J 75:1235-42. 2011
  2. doi Tissue Factor: A Conventional or Alternative Target in Cancer Therapy
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, CC04, Institut fur Klinische Pharmakologie und Toxikologie, Berlin, Germany
    Clin Chem 62:563-70. 2016
  3. doi The impact of microRNAs on the regulation of tissue factor biology
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Mitte, 10117 Berlin, Germany Electronic address
    Trends Cardiovasc Med 24:128-32. 2014
  4. doi Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, D 12200 Berlin, Germany
    Oncol Rep 30:462-70. 2013
  5. doi Upregulation of tissue factor expression and thrombogenic activity in human aortic smooth muscle cells by irradiation, rapamycin and paclitaxel
    Andreas Eisenreich
    Charitè Campus Benjamin Franklin CharitéCentrum 11 für Herz, Kreislauf und Gefässmedizin, Berlin, Germany
    Int Immunopharmacol 8:307-11. 2008
  6. doi PI3K inhibitors in cardiovascular disease
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, 12200 Berlin, Germany
    Cardiovasc Ther 29:29-36. 2011
  7. ncbi Role of the phosphatidylinositol 3-kinase/protein kinase B pathway in regulating alternative splicing of tissue factor mRNA in human endothelial cells
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, Berlin, Germany
    Circ J 73:1746-52. 2009
  8. doi Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, Berlin, Germany
    Circ Res 104:589-99. 2009
  9. doi Bivalirudin inhibits periprocedural platelet function and tissue factor expression of human smooth muscle cells
    Wojciech Pepke
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, Berlin, Germany
    Cardiovasc Ther 31:115-23. 2013
  10. doi Regulation and differential role of the tissue factor isoforms in cardiovascular biology
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, Berlin, Germany
    Trends Cardiovasc Med 20:199-203. 2010

Collaborators

Detail Information

Publications18

  1. ncbi Overexpression of alternatively spliced tissue factor induces the pro-angiogenic properties of murine cardiomyocytic HL-1 cells
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, Berlin, Germany
    Circ J 75:1235-42. 2011
    ....
  2. doi Tissue Factor: A Conventional or Alternative Target in Cancer Therapy
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, CC04, Institut fur Klinische Pharmakologie und Toxikologie, Berlin, Germany
    Clin Chem 62:563-70. 2016
    ..Therefore, targeting TF either by direct inhibition or indirectly, i.e., on a posttranscriptional level, offers a novel therapeutic option for cancer treatment...
  3. doi The impact of microRNAs on the regulation of tissue factor biology
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Mitte, 10117 Berlin, Germany Electronic address
    Trends Cardiovasc Med 24:128-32. 2014
    ..In the present review, we will summarize and discuss the latest findings regarding the impact of miRNAs on the generation of TF and its isoforms as well as on regulation of TF biology under normal and pathophysiologic conditions. ..
  4. doi Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, D 12200 Berlin, Germany
    Oncol Rep 30:462-70. 2013
    ..Taken together, our results suggest that the pro-angiogenic potential of A549 lung cancer cells is modulated under hypoxic conditions via modulation of TF isoform expression which in turn is controlled by alternative splicing...
  5. doi Upregulation of tissue factor expression and thrombogenic activity in human aortic smooth muscle cells by irradiation, rapamycin and paclitaxel
    Andreas Eisenreich
    Charitè Campus Benjamin Franklin CharitéCentrum 11 für Herz, Kreislauf und Gefässmedizin, Berlin, Germany
    Int Immunopharmacol 8:307-11. 2008
    ..Tissue factor (TF) may contribute to late thrombosis. This study examined the impact of rapamycin and paclitaxel on TF expression and compares the TF activity induction of both drugs and irradiation in SMCs...
  6. doi PI3K inhibitors in cardiovascular disease
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, 12200 Berlin, Germany
    Cardiovasc Ther 29:29-36. 2011
    ..Therefore, this review will focus on the pathophysiologic role of class I PI3Ks in cardiovascular diseases as well as on the therapeutic potential of pharmacological PI3K inhibitors for the treatment of this scourge of humanity...
  7. ncbi Role of the phosphatidylinositol 3-kinase/protein kinase B pathway in regulating alternative splicing of tissue factor mRNA in human endothelial cells
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, Berlin, Germany
    Circ J 73:1746-52. 2009
    ..This study compared the impact of PI3K/Akt pathway inhibition on alternative splicing of TF in HUVECs, to the influence of transcriptional regulation by inhibiting nuclear factor kappa B (NFkappaB)...
  8. doi Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, Berlin, Germany
    Circ Res 104:589-99. 2009
    ..This study is the first to demonstrate that serine/arginine-rich protein kinases modulate splicing of TF pre-mRNA in human endothelial cells and, consequently, endothelial procoagulant activity under inflammatory conditions...
  9. doi Bivalirudin inhibits periprocedural platelet function and tissue factor expression of human smooth muscle cells
    Wojciech Pepke
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, Berlin, Germany
    Cardiovasc Ther 31:115-23. 2013
    ..Further, the effect of bivalirudin on induced tissue factor (TF) expression in smooth muscle cells (SMC) was determined...
  10. doi Regulation and differential role of the tissue factor isoforms in cardiovascular biology
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, Berlin, Germany
    Trends Cardiovasc Med 20:199-203. 2010
    ..These data indicate that both TF isoforms influence diverse processes in cardiovascular (patho)biology and are potential targets for antithrombotic, pro-survival, and proangiogenic therapeutic strategies...
  11. ncbi Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis
    Petra Goldin-Lang
    Charite Universitatsmedizin Berlin, Charité Centrum 11 für Herz Kreislauf und Gefässmedizin, Campus Benjamin Franklin, Medical Clinic II, Department of Cardiology and Pneumology, 12200 Berlin, Germany
    Oncol Rep 20:123-8. 2008
    ..The up-regulation of flHTF and, especially, asHTF in AC suggests not only a raised risk of thrombosis, but also of tumor progression, thereby, indicating a poor prognosis in these patients...
  12. doi Prolonged clopidogrel application reduces tissue factor expression after percutaneous coronary intervention in the porcine model
    Yunus Ayral
    Department of Cardiology and Pneumonology, Medical Clinic II, Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
    Cardiovasc Revasc Med 12:47-55. 2011
    ....
  13. doi Effects of the Cdc2-like kinase-family and DNA topoisomerase I on the alternative splicing of eNOS in TNF-alpha-stimulated human endothelial cells
    Andreas Eisenreich
    Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Centrum für Herz und Kreislaufmedizin, D 12200 Berlin, Germany
    Biol Chem 389:1333-8. 2008
    ....
  14. doi CCN1: a novel inflammation-regulated biphasic immune cell migration modulator
    Madlen Löbel
    Institute of Medical Immunology, Charite University Medicine Berlin, 13353, Berlin, Germany
    Cell Mol Life Sci 69:3101-13. 2012
    ....
  15. doi Leptin and resistin induce increased procoagulability in diabetes mellitus
    Peter Bobbert
    Department of Cardiology and Pneumology, Charite Universitatsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany
    Cytokine 56:332-7. 2011
    ..This study was performed to elucidate the role of the adipocytokines leptin and resistin in the development of hypercoagulability and hypofibrinolysis under diabetic conditions...
  16. doi The role of tissue factor isoforms in cancer biology
    Ulrike Leppert
    Charite Universitatsmedizin Berlin, Campus Mitte, Charite Centrum 04 13, Berlin, Germany
    Int J Cancer 137:497-503. 2015
    ..Moreover, we will summarize and discuss the latest findings regarding the role of TF and its isoforms in cancer biology. ..
  17. doi Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator
    Madlen Rother
    Institute for Medical Immunology, Charite Campus, Berlin, Germany
    Circulation 122:2688-98. 2010
    ..Here, we provide evidence of a novel function of CCN1 as a modulator of immune cell migration...